{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:03:37Z","timestamp":1791248617154,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.04.058","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T13:00:19Z","timestamp":1335790819000},"page":"4709-4716","source":"Crossref","is-referenced-by-count":35,"title":["Research priorities for global measles and rubella control and eradication"],"prefix":"10.1016","volume":"30","author":[{"given":"James L.","family":"Goodson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Featherstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Reef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Strebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0005","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/infdis\/jir075","article-title":"The Measles Initiative: moving toward measles eradication","volume":"204","author":"Christie","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jir111","article-title":"A world without measles","volume":"204","author":"Strebel","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0015","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/infdis\/jir100","article-title":"Proceedings of the global technical consultation to assess the feasibility of measles eradication, 28\u201330 July 2010","volume":"204","author":"World Health Organization","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0020","first-page":"73","article-title":"Progress in global measles control, 2000\u20132010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"49","key":"10.1016\/j.vaccine.2012.04.058_bib0025","first-page":"490","article-title":"Monitoring progress towards measles elimination","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Weekly Epidemiological Record"},{"issue":"47","key":"10.1016\/j.vaccine.2012.04.058_bib0030","first-page":"1321","article-title":"Global measles mortality, 2000\u20132008","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"40","key":"10.1016\/j.vaccine.2012.04.058_bib0035","first-page":"439","article-title":"Progress in implementing measles mortality reduction strategies, India 2010\u20132011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Weekly Epidemiological Record"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0040","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1093\/infdis\/jir061","article-title":"The heterogeneity of measles epidemiology in India: implications for improving control measures","volume":"204","author":"Murhekar","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0045","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.1093\/infdis\/jir062","article-title":"Measles in rural West Bengal, India, 2005\u20136: low recourse to the public sector limits the use of vitamin A and the sensitivity of surveillance","volume":"204","author":"Murhekar","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.058_bib0050","first-page":"374","article-title":"Measles outbreaks and progress toward measles preelimination\u2014African region, 2009\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0055","unstructured":"EUVAC.net. Measles surveillance annual report 2010. Copenhagen, Denmark: Statens Serum Institute; 2010, http:\/\/www.euvac.net\/graphics\/euvac\/pdf\/annual_2010.pdf [accessed 10.02.12]."},{"key":"10.1016\/j.vaccine.2012.04.058_bib0060","first-page":"1520","article-title":"Global routine vaccination coverage, 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.058_bib0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S0950268800004672","article-title":"The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiology and Infection"},{"issue":"35","key":"10.1016\/j.vaccine.2012.04.058_bib0070","first-page":"349","article-title":"Measles vaccines: WHO position paper","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Weekly Epidemiological Record"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0075","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1086\/377741","article-title":"Measles eradication in the Americas: progress to date","volume":"189","author":"de Quadros","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"37","key":"10.1016\/j.vaccine.2012.04.058_bib0080","first-page":"969","article-title":"Progress in measles control\u2014Kenya 2002\u20132007","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"42","key":"10.1016\/j.vaccine.2012.04.058_bib0085","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1016\/j.vaccine.2009.07.057","article-title":"Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania","volume":"27","author":"Goodson","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.058_bib0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ije\/dyi001","article-title":"Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002","volume":"34","author":"Yameogo","year":"2005","journal-title":"International Journal of Epidemiology"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0095","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1093\/infdis\/jir106","article-title":"Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals","volume":"204","author":"Hickman","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0100","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1093\/infdis\/jir098","article-title":"Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission","volume":"204","author":"Rota","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"7179","key":"10.1016\/j.vaccine.2012.04.058_bib0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature06509","article-title":"The dynamics of measles in sub-Saharan Africa","volume":"451","author":"Ferrari","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.058_bib0110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/oxfordjournals.aje.a114415","article-title":"Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody","volume":"124","author":"Black","year":"1986","journal-title":"American Journal of Epidemiology"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0115","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/170.Supplement_1.S32","article-title":"Successes and failures in measles control","volume":"170","author":"Cutts","year":"1994","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0120","first-page":"2010","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study","author":"Leuridan","year":"2010","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.058_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1743-422X-7-87","article-title":"Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination","volume":"7","author":"Zhao","year":"2010","journal-title":"Virology Journal"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0130","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1093\/infdis\/jir129","article-title":"Changing epidemiology of measles in Africa","volume":"204","author":"Goodson","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0135","doi-asserted-by":"crossref","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"British Medical Journal"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0140","doi-asserted-by":"crossref","first-page":"a661","DOI":"10.1136\/bmj.a661","article-title":"Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial","volume":"337","author":"Martins","year":"2008","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.058_bib0145","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/522989","article-title":"The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants","volume":"45","author":"Scott","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.058_bib0150","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0027-9684(15)31545-5","article-title":"Immunity to measles in pregnant mothers and in cord blood of their infants: impact of HIV status and mother's place of birth","volume":"100","author":"Choudhury","year":"2008","journal-title":"Journal of the National Medical Association"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.058_bib0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519169","article-title":"Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study","volume":"196","author":"Moss","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"16","key":"10.1016\/j.vaccine.2012.04.058_bib0160","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.vaccine.2011.02.013","article-title":"Long-term safety and serologic response to measles: mumps, and rubella vaccination in HIV-1 infected adults","volume":"29","author":"Stermole","year":"2011","journal-title":"Vaccine"},{"issue":"1695","key":"10.1016\/j.vaccine.2012.04.058_bib0165","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1098\/rspb.2010.0536","article-title":"Rural\u2013urban gradient in seasonal forcing of measles transmission in Niger","volume":"277","author":"Ferrari","year":"2010","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.058_bib0170","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2011.11.020","article-title":"Devices for intradermal vaccination","volume":"30","author":"Kis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/hv.1.1.1423","article-title":"Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis","volume":"26","author":"Low","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0180","doi-asserted-by":"crossref","first-page":"S491","DOI":"10.1093\/infdis\/jir107","article-title":"Expansion of the Global Measles and Rubella Laboratory Network 2005\u201309","volume":"204","author":"Featherstone","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.04.058_bib0185","doi-asserted-by":"crossref","first-page":"S683","DOI":"10.1093\/infdis\/jir471","article-title":"Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas","volume":"204","author":"Castillo-Solrzano","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0190","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1093\/infdis\/jir118","article-title":"Global distribution of measles genotypes and measles molecular epidemiology","volume":"204","author":"Rota","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.058_bib0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"Journal of Virological Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.058_bib0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JCM.38.1.99-104.2000","article-title":"Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles","volume":"38","author":"Ratnam","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"issue":"27","key":"10.1016\/j.vaccine.2012.04.058_bib0205","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.04.058_bib0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jviromet.2007.08.021","article-title":"An indirect immunocolorimetric assay to detect rubella virus infected cells","volume":"146","author":"Chen","year":"2007","journal-title":"Journal of Virological Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0215","doi-asserted-by":"crossref","first-page":"S506","DOI":"10.1093\/infdis\/jir117","article-title":"Improving global virologic surveillance for measles and rubella","volume":"204","author":"Rota","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"6044","key":"10.1016\/j.vaccine.2012.04.058_bib0220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/318323a0","article-title":"Vaccination and herd immunity to infectious diseases","volume":"318","author":"Anderson","year":"1985","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0225","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1093\/infdis\/jir119","article-title":"Comparing measles with previous eradication programs: enabling and constraining factors","volume":"204","author":"Keegan","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0230","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1093\/infdis\/jir137","article-title":"What will it take to achieve measles elimination in the World Health Organization European region: progress from 2003\u20132009 and essential accelerated actions","volume":"204","author":"Martin","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0235","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/infdis\/jir772","article-title":"Economic evaluation of a child health days strategy to deliver multiple maternal and child health interventions in Somalia","volume":"205","author":"Vijayaraghavan","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"9317","key":"10.1016\/j.vaccine.2012.04.058_bib0240","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(02)08517-3","article-title":"First 5 years of measles elimination in southern Africa: 1996\u20132000","volume":"359","author":"Biellik","year":"2002","journal-title":"The Lancet"},{"issue":"9488","key":"10.1016\/j.vaccine.2012.04.058_bib0245","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(05)67216-9","article-title":"Public-health impact of accelerated measles control in the WHO African region 2000\u201303","volume":"366","author":"Otten","year":"2005","journal-title":"The Lancet"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2012.04.058_bib0250","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1016\/j.vaccine.2004.02.042","article-title":"Economic analysis of the 1996\u20131997 mass measles immunization campaigns in South Africa","volume":"22","author":"Uzicanin","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.058_bib0255","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4269\/ajtmh.2010.09-0599","article-title":"Rapid scale-up of long-lasting insecticide-treated bed nets through integration into the national immunization program during child health week in Togo: 2004","volume":"83","author":"Wolkon","year":"2010","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.058_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.healthpol.2006.11.008","article-title":"Measles supplemental immunization activities improve measles vaccine coverage and equity: evidence from Kenya, 2002","volume":"83","author":"Vijayaraghavan","year":"2007","journal-title":"Health Policy"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0265","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3156.2011.02953.x","article-title":"Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar","author":"Goodson","year":"2012","journal-title":"Tropical Medicine & International Health"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0270","series-title":"Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage","author":"World Health Organisation","year":"2001"},{"issue":"9790","key":"10.1016\/j.vaccine.2012.04.058_bib0275","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","article-title":"Addressing the vaccine confidence gap","volume":"378","author":"Larson","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1098\/rsif.2007.1038","article-title":"Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger","volume":"5","author":"Grais","year":"2008","journal-title":"Journal of the Royal Society Interface"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0285","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1093\/infdis\/jir151","article-title":"Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009","volume":"204","author":"Goodson","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0290","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/infdis\/jir072","article-title":"Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update","volume":"204","author":"Cairns","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0295","unstructured":"World Health Organization. Response to measles outbreaks in measles mortality reduction strategies; 2009."},{"issue":"9557","key":"10.1016\/j.vaccine.2012.04.058_bib0300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(07)60107-X","article-title":"Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study","volume":"369","author":"Wolfson","year":"2007","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0305","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1086\/368114","article-title":"The global burden of measles in the year 2000\u2014a model that uses country-specific indicators","volume":"187","author":"Stein","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"9454","key":"10.1016\/j.vaccine.2012.04.058_bib0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(05)17715-0","article-title":"Measles surveillance: the importance of finding the tip of the iceberg","volume":"365","author":"Papania","year":"2005","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0315","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1086\/378501","article-title":"Completeness of measles case reporting: review of estimates for the United States","volume":"189","author":"Harpaz","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.058_bib0320","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/infdis\/jir115","article-title":"Health care\u2013associated measles outbreak in the United States after an importation: challenges and economic impact","volume":"203","author":"Chen","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.058_bib0325","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa060775","article-title":"Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States","volume":"355","author":"Parker","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.058_bib0330","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2004-2512","article-title":"The cost of containing one case of measles: the economic impact on the public health infrastructure\u2014Iowa, 2004","volume":"116","author":"Dayan","year":"2005","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.058_bib0335","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","article-title":"Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated","volume":"125","author":"Sugerman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0340","first-page":"161","article-title":"WHO position paper on rubella vaccines","volume":"75","author":"World Health Organization","year":"2000","journal-title":"Weekly Epidemiological Record"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.058_bib0345","first-page":"55","article-title":"Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS","volume":"75","author":"Cutts","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2012.04.058_bib0350","unstructured":"World Health Organisation. WHO supports GAVI Board decision to open a funding window for human papillomavirus and rubella vaccines. Department of Immunization, Vaccines and Biologicals, WHO, \/[accessed 10.02.12]."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0355","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/jir155","article-title":"Progress toward control of rubella and prevention of congenital rubella syndrome\u2014worldwide, 2009","volume":"204","author":"Reef","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"48","key":"10.1016\/j.vaccine.2012.04.058_bib0360","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1016\/j.vaccine.2011.08.061","article-title":"Rubella vaccines: WHO position paper\u2014recommendations","volume":"29","author":"World Health Organizaiton","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0365","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1093\/infdis\/jir216","article-title":"Measles and rubella elimination initiatives in the Americas: lessons learned and best practices","volume":"204","author":"Castillo Solorzano","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0370","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/infdis\/jir108","article-title":"Rubella epidemiology in Africa in the prevaccine era, 2002\u20132009","volume":"204","author":"Goodson","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.04.058_bib0375","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1093\/infdis\/jir437","article-title":"Lessons learned from integrated surveillance of measles and rubella in the Caribbean","volume":"204","author":"Irons","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"9454","key":"10.1016\/j.vaccine.2012.04.058_bib0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(05)17703-4","article-title":"Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment","volume":"365","author":"Bloom","year":"2005","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0385","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/infdis\/jir078","article-title":"Developing rubella vaccination policy in Nepal\u2014results from rubella surveillance and seroprevalence and congenital rubella syndrome studies","volume":"204","author":"Upreti","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.04.058_bib0390","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.1093\/infdis\/jir472","article-title":"Elimination of rubella and congenital rubella syndrome in the Americas","volume":"204","author":"Castillo-Solrzano","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0395","doi-asserted-by":"crossref","first-page":"S524","DOI":"10.1093\/infdis\/jir099","article-title":"Status of global virologic surveillance for rubella viruses","volume":"204","author":"Abernathy","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.058_bib0400","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/jir096","article-title":"Global eradication of measles: an epidemiologic and economic evaluation","volume":"204","author":"Levin","year":"2011","journal-title":"Journal of Infectious Diseases"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:29:46Z","timestamp":1642166986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12005944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":80,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X12005944"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}